Verthermia Selects Merge eClinicalOS® for Whole Body Hyperthermia Ovarian Cancer Treatment Trial

By November 6, 2014Press Release
Merge_by_IBM_-_verthermia_cancer-treatment

Verthermia, Inc. has selected the eClinicalOS data management platform from Merge eClinical for its clinical trial exploring the potential of whole body hyperthermia as a standalone treatment for women with Stage III or IV ovarian cancer. For more information, read Merge’s press release.